How much cash does Karuna Therapeutics have?

According to Karuna Therapeutics's latest annual financial reports, the company has a total of $185.82M in cash and cash equivalents. This amount includes all liquid assets that can be readily converted into cash.

Additionally, Karuna Therapeutics holds $1.08B in short-term investments, which are highly liquid assets that can be easily converted into cash within a short period.

In total, the company has $1.26B when combining cash and cash equivalents with short-term investments.

On a per-share basis, Karuna Therapeutics has $34.17 in cash. This metric helps investors understand how much cash the company holds per outstanding share.

The company's free cash flow, which is the cash generated from operations after deducting capital expenditures, stands at $-388.74M. This is an important indicator of financial health, showing the cash available for distribution to shareholders or reinvestment into the company.

Lastly, the company's cash position has experienced a growth rate of -25.17%, reflecting the increase in cash and cash equivalents over the specified period.

Karuna Therapeutics Historical Cash on Hand

Cash on Hand History

The table below shows the amount of cash on hand for each year, with the latest data available for the last fiscal year 2023.

Year	Cash on Hand	Change
2023	$185.82M	-25.17%
2022	$248.33M	19.99%
2021	$206.95M	290.12%
2020	$53.05M	-74.61%
2019	$208.93M	144.29%
2018	$85.53M	4304.02%
2017	$1.94M	N/A